Publication:
Is clinical disease activity index (CDAI) a reliable parameter in the assessment of rheumatoid arthritis patients treated with TNF antagonists?

Simple item page
dc.contributor.authorsInanc, N.; Direskeneli, H.
dc.date.accessioned2022-03-12T15:59:45Z
dc.date.accessioned2026-01-10T20:34:23Z
dc.date.available2022-03-12T15:59:45Z
dc.date.issued2007
dc.identifier.doidoiWOS:000253101100553
dc.identifier.issn0003-4967
dc.identifier.urihttps://hdl.handle.net/11424/224498
dc.identifier.wosWOS:000253101100553
dc.language.isoeng
dc.publisherB M J PUBLISHING GROUP
dc.relation.ispartofANNALS OF THE RHEUMATIC DISEASES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleIs clinical disease activity index (CDAI) a reliable parameter in the assessment of rheumatoid arthritis patients treated with TNF antagonists?
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage173
oaire.citation.startPage173
oaire.citation.titleANNALS OF THE RHEUMATIC DISEASES
oaire.citation.volume66

Files

Collections

Araştırma Çıktıları